AR061055A1 - Sal de hemicitrato de 2,3-dicloro-n-ciclopentil-n-((3s)-pirrolidin-3-il)benzamida - Google Patents
Sal de hemicitrato de 2,3-dicloro-n-ciclopentil-n-((3s)-pirrolidin-3-il)benzamidaInfo
- Publication number
- AR061055A1 AR061055A1 ARP070102190A ARP070102190A AR061055A1 AR 061055 A1 AR061055 A1 AR 061055A1 AR P070102190 A ARP070102190 A AR P070102190A AR P070102190 A ARP070102190 A AR P070102190A AR 061055 A1 AR061055 A1 AR 061055A1
- Authority
- AR
- Argentina
- Prior art keywords
- ciclopentil
- benzamida
- pirrolidin
- dicloro
- hemicitrate
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 2
- MPGDFMOXIHFZSL-LBPRGKRZSA-N 2,3-dichloro-n-cyclopentyl-n-[(3s)-pyrrolidin-3-yl]benzamide Chemical compound ClC1=CC=CC(C(=O)N(C2CCCC2)[C@@H]2CNCC2)=C1Cl MPGDFMOXIHFZSL-LBPRGKRZSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe una sal farmacéuticamente y veterinariamente aceptable mejorada de 2,3-dicloro-N-ciclopentil-N-[(3S)-pirrolidin-3-iI]benzamida y composiciones de la misma. Reivindicacion 1: Hemicitrato de 2,3-dicloro-N-ciclopentil-N-[(3S)-pirrolidin-3- il]benzamida. Reivindicacion 2: Un compuesto de acuerdo con la reivindicacion 1 caracterizado por un patron de difraccion de rayos X en polvo (PXRD) el cual muestra picos principales a 12,9, 15,0, 15,2, 18,4 y 20,0 grados 2theta+- 0,1° cuando se mide usando radiacion CuKalfa (longitud de Á).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74787706P | 2006-05-22 | 2006-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061055A1 true AR061055A1 (es) | 2008-07-30 |
Family
ID=38723668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102190A AR061055A1 (es) | 2006-05-22 | 2007-05-21 | Sal de hemicitrato de 2,3-dicloro-n-ciclopentil-n-((3s)-pirrolidin-3-il)benzamida |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2007314534A (es) |
| AR (1) | AR061055A1 (es) |
| TW (1) | TW200815341A (es) |
| WO (1) | WO2007135530A2 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1638933T1 (sl) * | 2003-06-17 | 2008-10-31 | Pfizer | Derivati N-pirolidin-3-il-amida kot inhibitorji ponovnega privzema serotonina in noradrenalina |
| GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
-
2007
- 2007-05-10 WO PCT/IB2007/001296 patent/WO2007135530A2/en not_active Ceased
- 2007-05-21 AR ARP070102190A patent/AR061055A1/es unknown
- 2007-05-21 TW TW096118025A patent/TW200815341A/zh unknown
- 2007-05-21 JP JP2007133943A patent/JP2007314534A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007135530A3 (en) | 2008-03-27 |
| JP2007314534A (ja) | 2007-12-06 |
| TW200815341A (en) | 2008-04-01 |
| WO2007135530A2 (en) | 2007-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2539430T3 (es) | Derivados de metastina y uso de los mismos | |
| PT2404906E (pt) | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa | |
| EA200801341A1 (ru) | КОНДЕНСИРОВАННЫЕ БИЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ mTOR | |
| EA200801381A1 (ru) | Производные пиримидина | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| CY1105994T1 (el) | Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων | |
| DK1529044T5 (da) | Dehydrophenylahistiner og analoger deraf og syntesen af dehydrophenylahistiner og analoger deraf | |
| WO2007076348A3 (en) | Azaindole inhibitors of aurora kinases | |
| WO2007029035A3 (en) | Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors | |
| CR8827A (es) | Compuesto heterociclico fusionado | |
| CY1105826T1 (el) | Μεθοδος συνθεσης του (1s)-4,5-διμεθοξυ-1-(μεθυλαμινομεθυλ)βενζοκυκλοβουτανιου και των αλατων προσθηκης αυτου και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης αυτης με φαρμακευτικως αποδεκτο οξυ | |
| EA200601274A1 (ru) | Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
| EA200970669A1 (ru) | Производные 2-амино-5,7-дигидро-6н-пирроло[3,4-d]пиримидина в качестве ингибиторов hsp-90, предназначенные для лечения рака | |
| EA200970124A1 (ru) | Производные 2-арилиндола в качестве ингибиторов npges-1 | |
| WO2007014054A3 (en) | Benzenesulfonamide inhibitor of ccr2 chemokine receptor | |
| EA200970373A1 (ru) | АНТИДЕПРЕССАНТ, НЕЙРОПРОТЕКТОР, ИНГИБИТОР ОТЛОЖЕНИЙ β-АМИЛОИДА ИЛИ СРЕДСТВО, ЗАМЕДЛЯЮЩЕЕ СТАРЕНИЯ, СОДЕРЖАЩИЕ ГЕТЕРОЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ КОНКРЕТНОЙ СТРУКТУРЫ | |
| DE60319080D1 (de) | Phenyloxyalkansäure-derivate als hppar aktivatore | |
| DK2016051T3 (da) | Beta-krystallinsk form for perindoprilargininsalt, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette | |
| DE602005019316D1 (en) | Aromatische etherderivate als thrombin-hemmer | |
| AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
| WO2008068610A3 (en) | Photoactive compounds | |
| DOP2011000154A (es) | 3-aminociclopentancarboxamidas | |
| EP1906238A3 (en) | Photosensitive composition and pattern forming method using the same | |
| AR061055A1 (es) | Sal de hemicitrato de 2,3-dicloro-n-ciclopentil-n-((3s)-pirrolidin-3-il)benzamida | |
| WO2007017728A3 (en) | Novel heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |